Bill Sponsor
Senate Bill 133
118th Congress(2023-2024)
NAPA Reauthorization Act
Active
Amendments
Active
Passed Senate on Jul 30, 2024
Overview
Text
Introduced
Jan 30, 2023
Latest Action
Aug 2, 2024
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
133
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Maine
Republican
Arkansas
Democrat
Delaware
Republican
Florida
Democrat
Massachusetts
Democrat
Michigan
Democrat
Minnesota
Democrat
Minnesota
Republican
Mississippi
Republican
Mississippi
Republican
Missouri
Republican
Nebraska
Democrat
New Hampshire
Democrat
New Jersey
Democrat
New Jersey
Republican
North Carolina
Republican
North Carolina
Republican
North Dakota
Democrat
Rhode Island
Democrat
Rhode Island
Republican
South Dakota
Democrat
Virginia
Democrat
Washington
Senate Votes (1)
House Votes (0)
checkPassed on July 30, 2024
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (text: CR S5568-5569)
Summary

NAPA Reauthorization Act

This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.

In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.

The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).

Text (3)
July 30, 2024
July 27, 2023
January 30, 2023
Amendments (1)
Jul 30, 2024
Agreed to in Senate
1
Sponsorship
Senate Amendment 3201
In the nature of a substitute.
Agreed To
Actions (12)
08/02/2024
Held at the desk.
08/02/2024
Received in the House.
07/31/2024
Message on Senate action sent to the House.
07/30/2024
Passed Senate with an amendment by Voice Vote. (text: CR S5568-5569)
07/30/2024
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (text: CR S5568-5569)
07/30/2024
The committee substitute withdrawn by Unanimous Consent.
07/30/2024
Measure laid before Senate by unanimous consent. (consideration: CR S5568-5569)
07/27/2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 182.
07/27/2023
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment in the nature of a substitute. Without written report.
06/15/2023
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
01/30/2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S150-151)
01/30/2023
Introduced in Senate
Public Record
Record Updated
Sep 5, 2024 2:26:51 PM